About me
Dr. Castle is a technical leader in Eli Lilly & Company's Synthetic Molecule Design and Development organization. He has been part of the Lilly team for over 25 years and has held many different roles in drug substance and drug product analytical development. He currently is engaged in driving the analytical strategy for synthetic molecule commercialization portfolio. Dr. Castle is passionate about people development, efficiency tools, which include excellence in chromatographic separations, automation, and enabling of scientists through better handling of laboratory data. External to Lilly, he is engaged in ICH Q2(R2) and Q14 activities by co-leading a team at ISPE-PQLI.
